Eliminate
Cancer
from the world

We are developing drugs for pancreatic cancer and small cell lung cancer.

News

2025.08.01

Our CEO, Dr. Nishino, gave a presentation at the "International Open Innovation & Startup Symposium 2025" held on Wednesday, July 23, hosted by Institute of Science Tokyo. We would like to extend our sincere gratitude to everyone who attended the session. We remain committed to accelerating the development of innovative treatments for highly malignant cancers, and delivering them to patients as quickly as possible. (Check out the event highlights here)

2025.07.18

Our CEO, Dr. Nishino, will be speaking at the "International Open Innovation & Startup Symposium 2025," hosted by Institute of Science Tokyo, on Wednesday, July 23. We would be honored if you could attend and listen to his talk.(For details, click here)

2025.06.24

Our website has been updated, and now includes information on each of our pipelines. We encourage you to visit and explore the new content.

See More

Research Content

We are working on developing innovative treatments for highly malignant cancers (pancreatic cancer, small cell lung cancer, etc.)

Small Cell Lung Cancer Icon

Small Cell Lung Cancer

Developing small molecule compounds that inhibit metabolic enzymes highly expressed in small cell lung cancer, promoting new treatment realization.

Learn More
Pancreatic Cancer Icon

Pancreatic Cancer

Developing antibody therapy targeting signal paths specific to pancreatic cancer stem cells, aiming for clinical application.

Learn More
All Cancers Icon

All Cancers

Developing therapeutic agents targeting all solid tumors by inhibiting cancer stem cell-specific ubiquitin ligase E3.

Learn More